LifeStance Health (LFST) Capital Expenditures (2020 - 2026)

LifeStance Health (LFST) has 7 years of Capital Expenditures data on file, last reported at $10.8 million in Q1 2026.

• Quarterly Capital Expenditures rose 50.21% year-over-year to $10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.7 million (up 68.11% YoY) and the FY2025 annual result came in at $36.1 million, up 67.51% from the prior year.
• Capital Expenditures slipped to $10.8 million in Q1 2026 per LFST's latest filing, from $10.9 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $27.9 million in Q1 2022 and bottomed at $5.1 million in Q3 2024.
• The 5-year median for Capital Expenditures is $10.3 million (2025), against an average of $11.1 million.
• Peak annual rise in Capital Expenditures reached 151.87% in 2022, while the deepest fall reached 73.15% in 2022.
• Tracing LFST's Capital Expenditures over 5 years: stood at $10.4 million in 2022, then grew by 9.92% to $11.4 million in 2023, then plunged by 44.8% to $6.3 million in 2024, then surged by 73.16% to $10.9 million in 2025, then declined by 1.32% to $10.8 million in 2026.
• Per Business Quant, the three latest LFST Capital Expenditures figures stand at $10.8 million (Q1 2026), $10.9 million (Q4 2025), and $10.3 million (Q3 2025).

Peer Comparison